HUE038120T2 - Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra - Google Patents

Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra

Info

Publication number
HUE038120T2
HUE038120T2 HUE11711655A HUE11711655A HUE038120T2 HU E038120 T2 HUE038120 T2 HU E038120T2 HU E11711655 A HUE11711655 A HU E11711655A HU E11711655 A HUE11711655 A HU E11711655A HU E038120 T2 HUE038120 T2 HU E038120T2
Authority
HU
Hungary
Prior art keywords
transferrin
prophylaxis
treatment
autoimmune diseases
autoimmune
Prior art date
Application number
HUE11711655A
Other languages
English (en)
Inventor
Claudio Farina
Ester Ascione
Pierangelo Giovacchini
Ferdinando Nicoletti
Original Assignee
Kedrion Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kedrion Spa filed Critical Kedrion Spa
Publication of HUE038120T2 publication Critical patent/HUE038120T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE11711655A 2010-02-15 2011-02-15 Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra HUE038120T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI2010A000020A IT1398032B1 (it) 2010-02-15 2010-02-15 Transferrina per il trattamento di malattie autoimmuni.

Publications (1)

Publication Number Publication Date
HUE038120T2 true HUE038120T2 (hu) 2018-09-28

Family

ID=42542741

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE11711655A HUE038120T2 (hu) 2010-02-15 2011-02-15 Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra

Country Status (7)

Country Link
US (1) US9138454B2 (hu)
EP (1) EP2536419B1 (hu)
CA (1) CA2787727C (hu)
ES (1) ES2674326T3 (hu)
HU (1) HUE038120T2 (hu)
IT (1) IT1398032B1 (hu)
WO (1) WO2011098990A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
EP3318256A1 (en) 2016-11-08 2018-05-09 Quimatryx, S.L Compounds for the treatment of autoimmune diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0696455A1 (en) 1994-08-11 1996-02-14 Cellena (Cell Engineering) A.G. Transferrin compositions to alleviate the side effects of cytotoxic drugs
WO1996014862A1 (en) 1994-11-10 1996-05-23 Cellena Ag Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens
US5849293A (en) 1996-01-11 1998-12-15 Cornell Research Foundation, Inc. Use of human transferrin in controlling insulin levels
US6126955A (en) 1998-04-16 2000-10-03 University Of Utah Research Foundation Apo-transferrin as a potent inhibitor of bacterial adhesion to biomaterials
US6326473B1 (en) * 1998-12-30 2001-12-04 Suomen Punainen Risti Veripalvelu Pharmaceutical preparations
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
WO2007076505A2 (en) * 2005-12-28 2007-07-05 Essential Skincare, Llc Transferrin and transferrin-based compositions for diabetes treatment
ITLU20070009A1 (it) 2007-05-21 2008-11-22 Kedrion Spa Uso di transferrina per la preparazione di composizioni farmaceutiche utili per il trattamento di infezioni batteriche come coadiuvanti nella terapia antibiotica.
EA201071059A1 (ru) * 2008-03-11 2011-04-29 Лайвайонекс Инк. Способы и композиции для лечения воспаления и связанных с воспалением патологических состояний

Also Published As

Publication number Publication date
US20120296071A1 (en) 2012-11-22
CA2787727A1 (en) 2011-08-18
WO2011098990A1 (en) 2011-08-18
ITFI20100020A1 (it) 2011-08-16
US9138454B2 (en) 2015-09-22
ES2674326T3 (es) 2018-06-28
IT1398032B1 (it) 2013-02-07
EP2536419A1 (en) 2012-12-26
EP2536419B1 (en) 2018-04-04
CA2787727C (en) 2018-08-21

Similar Documents

Publication Publication Date Title
HK1216176A1 (zh) 用於治療增殖性和自身免疫疾病的非對稱吡咯並苯並二氮雜卓二聚物
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
HK1180320A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
GB2478595B (en) Phytocannabinoids in the treatment of glioma
HK1180322A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd copd
EP2432462A4 (en) OXYGEN PROCEDURE AND COMPOSITIONS FOR THE TREATMENT OF MAMMALIAN DISEASES
PL2771041T3 (pl) Kompozycje i ich zastosowanie w gojeniu się kości
HK1185552A1 (en) Use of interleukin-22 in treating viral hepatitis -22
HK1164369A1 (en) Preparation of microvesicle-sirna composition and use of the same in aids treatment
PT2576782T (pt) Arnsi e utilização dos mesmos em métodos e composições para o tratamento e/ou prevenção de condições oculares
EP2575824A4 (en) METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
LT2845598T (lt) Preparatas, skirtas naudoti netipinės osteoporozės prevencijai ir gydymui
HK1203430A1 (en) Bisarylsulfonamides useful in the treatment of inflammation and cancer
EP2744786A4 (en) SUBSTITUTED 2-IMIDAZOLIDINONE AND 2-IMIDAZOLONE AND THEIR USE IN THE TREATMENT OF CANCER
IL222482A0 (en) Methods and compositions for the treatment of fluid accumulation in and/or under the retina
HRP20151393T8 (hr) UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE
HUE038120T2 (hu) Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra
HK1214771A1 (zh) 用於治療皮膚病的製劑
HK1208159A1 (en) Sorcs1 for use in the treatment of obesity and overweight sorcs1
ZA201401800B (en) Novel plant defensins and use in the treatment of proliferative diseases
IL220241A0 (en) Use of transferrin in treatment of beta-thalassemias
PT2389936E (pt) Aminaftona para utilização no tratamento e/ou prevenção de enxaqueca
IL231115A0 (en) Peptides for use in the treatment of diseases and disorders related to - 1 - il
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer